Zhejiang Ausun Pharmaceutical Co Ltd
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, … Read more
Zhejiang Ausun Pharmaceutical Co Ltd (603229) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.052x
Based on the latest financial reports, Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a cash flow conversion efficiency ratio of 0.052x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥121.49 Million) by net assets (CN¥2.35 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Ausun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Zhejiang Ausun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Ausun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Ausun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BALLYS CORP. DL-01
F:358
|
N/A |
|
Zhejiang Noblelift Equip
SHG:603611
|
0.154x |
|
Silex Systems Limited
OTCQX:SILXF
|
-0.005x |
|
FERRETTI S.P.A. O.N.
F:F3T1
|
N/A |
|
Apacer Technology Inc
TW:8271
|
0.014x |
|
SEPLF
PINK:SEPLF
|
0.292x |
|
KIRLOSKAR PNEUMATIC CO LTD
NSE:KIRLPNU
|
0.124x |
|
DFDS A/S
OTCGREY:DFDDF
|
0.056x |
Annual Cash Flow Conversion Efficiency for Zhejiang Ausun Pharmaceutical Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Ausun Pharmaceutical Co Ltd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.27 Billion | CN¥177.93 Million | 0.078x | -24.40% |
| 2023-12-31 | CN¥2.14 Billion | CN¥221.85 Million | 0.104x | +25.54% |
| 2022-12-31 | CN¥1.46 Billion | CN¥120.57 Million | 0.083x | -40.46% |
| 2021-12-31 | CN¥1.25 Billion | CN¥173.90 Million | 0.139x | +12.78% |
| 2020-12-31 | CN¥1.13 Billion | CN¥138.47 Million | 0.123x | -9.63% |
| 2019-12-31 | CN¥645.19 Million | CN¥87.73 Million | 0.136x | +606.38% |
| 2018-12-31 | CN¥597.60 Million | CN¥11.50 Million | 0.019x | -76.76% |
| 2017-12-31 | CN¥564.93 Million | CN¥46.78 Million | 0.083x | -78.38% |
| 2016-12-31 | CN¥243.30 Million | CN¥93.21 Million | 0.383x | +34.36% |
| 2015-12-31 | CN¥188.07 Million | CN¥53.63 Million | 0.285x | +3.96% |
| 2014-12-31 | CN¥78.21 Million | CN¥21.45 Million | 0.274x | -42.62% |
| 2013-12-31 | CN¥32.91 Million | CN¥15.73 Million | 0.478x | +534.85% |
| 2012-12-31 | CN¥10.36 Million | CN¥-1.14 Million | -0.110x | -- |